Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Pediatr Blood Cancer. 2011 Apr 7;57(6):939–942. doi: 10.1002/pbc.23129

Figure 1.

Figure 1

The treatment schema for patients enrolled on INT-0133. Abbreviations: High dose methotrexate (HDMTX), Cisplatin (CDDP), Doxorubicin (Doxo), Ifosfamide (Ifos), Muramyl Tripeptide Phosphatidylethanolamine (MTP-PE).